{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:00:16Z","timestamp":1787061616506,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"DOI":"10.1007\/s00592-025-02581-5","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T09:01:10Z","timestamp":1757494870000},"page":"105-114","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Expression of long non-coding RNAs MALAT1, MEG3, and XIST in gestational diabetes mellitus: a cross-sectional study"],"prefix":"10.1007","volume":"63","author":[{"given":"Bishal Kumar","family":"Dey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudipta","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieu","family":"Adhikary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhankar","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanchita","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subesha Basu","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0362-5036","authenticated-orcid":false,"given":"Rana","family":"Bhattacharjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,10]]},"reference":[{"key":"2581_CR1","doi-asserted-by":"publisher","unstructured":"American Diabetes Association. 2. Diagnosis and classification of diabetes: Standards of care in diabetes\u20142024. Diabetes Care (2024) ;47(Suppl 1):S20\u201342. https:\/\/doi.org\/10.2337\/dc24-S002","DOI":"10.2337\/dc24-S002"},{"key":"2581_CR2","doi-asserted-by":"publisher","unstructured":"Rosenberg EA, Seely EW (2023 Nov) Long-term cardiovascular disease after adverse pregnancy outcomes. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgad552","DOI":"10.1210\/clinem\/dgad552"},{"issue":"1","key":"2581_CR3","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1186\/s12884-021-04138-w","volume":"21","author":"P Quaresima","year":"2021","unstructured":"Quaresima P, Visconti F, Interlandi F, Puccio L, Caroleo P, Amendola G et al (2021) Awareness of gestational diabetes mellitus foetal-maternal risks: an Italian cohort study on pregnant women. BMC Pregnancy Childbirth 21(1):692. https:\/\/doi.org\/10.1186\/s12884-021-04138-w","journal-title":"BMC Pregnancy Childbirth"},{"issue":"3","key":"2581_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s13224-018-1197-0","volume":"69","author":"SS Khadilkar","year":"2019","unstructured":"Khadilkar SS (2019) Obesity in pregnancy: obstetrician\u2019s obstacle. J Obstet Gynaecol India 69(3):197\u2013202. https:\/\/doi.org\/10.1007\/s13224-018-1197-0","journal-title":"J Obstet Gynaecol India"},{"key":"2581_CR5","doi-asserted-by":"publisher","first-page":"108625","DOI":"10.1016\/j.diabres.2020.108625","volume":"171","author":"RA Dennison","year":"2021","unstructured":"Dennison RA, Chen ES, Green ME, Legard C, Kotecha D, Farmer G et al (2021) Absolute and relative risk of type 2 diabetes after gestational diabetes: A systematic review and meta-analysis. Diabetes Res Clin Pract 171:108625. https:\/\/doi.org\/10.1016\/j.diabres.2020.108625","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"2581_CR6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.pcd.2021.08.005","volume":"16","author":"BE Feleke","year":"2022","unstructured":"Feleke BE, Feleke TE, Adane WG, Kassahun MB, Girma A, Alebachew A et al (2022) Maternal and newborn effects of gestational diabetes mellitus: A prospective cohort study. Prim Care Diabetes 16(1):89\u201395. https:\/\/doi.org\/10.1016\/j.pcd.2021.08.005","journal-title":"Prim Care Diabetes"},{"key":"2581_CR7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/978-3-030-12668-1_14","volume":"1134","author":"L Khambule","year":"2019","unstructured":"Khambule L, George JA (2019) The role of inflammation in the development of GDM and the use of markers of inflammation in GDM screening. Adv Exp Med Biol 1134:217\u2013242. https:\/\/doi.org\/10.1007\/978-3-030-12668-1_14","journal-title":"Adv Exp Med Biol"},{"issue":"11","key":"2581_CR8","doi-asserted-by":"publisher","first-page":"944","DOI":"10.3275\/8999","volume":"36","author":"M Boyadzhieva","year":"2013","unstructured":"Boyadzhieva M, Atanasova I, Zacharieva S, Kedikova S (2013) Adipocytokines during pregnancy and postpartum in women with gestational diabetes and healthy controls. J Endocrinol Invest 36(11):944\u2013949. https:\/\/doi.org\/10.3275\/8999","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"2581_CR9","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L, Guo CJ, Chen LL, Huarte M (2021) Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol 22(2):96\u2013118. https:\/\/doi.org\/10.1038\/s41580-020-00315-9","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2581_CR10","doi-asserted-by":"publisher","first-page":"659313","DOI":"10.3389\/fendo.2021.659313","volume":"12","author":"C Dieter","year":"2021","unstructured":"Dieter C, Lemos NE, Corr\u00eaa NR, de Assmann F, Crispim TS (2021) The impact of LncRNAs in diabetes mellitus: A systematic review and in Silico analyses. Front Endocrinol (Lausanne) 12:659313. https:\/\/doi.org\/10.3389\/fendo.2021.659313","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2581_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-24907-w","volume":"8","author":"S Biswas","year":"2018","unstructured":"Biswas S, Thomas AA, Chen S, Aref-Eshghi E, Feng B, Gonder J et al (2018) MALAT1: an epigenetic regulator of inflammation in diabetic retinopathy. Sci Rep 8(1):1\u201315. https:\/\/doi.org\/10.1038\/s41598-018-24907-w","journal-title":"Sci Rep"},{"key":"2581_CR12","doi-asserted-by":"publisher","first-page":"109959","DOI":"10.1016\/j.biopha.2020.109959","volume":"125","author":"Y Dong","year":"2020","unstructured":"Dong Y, Wan G, Peng G, Yan P, Qian C, Li F (2020) Long non-coding RNA XIST regulates hyperglycemia-associated apoptosis and migration in human retinal pigment epithelial cells. Biomed Pharmacother 125:109959. https:\/\/doi.org\/10.1016\/j.biopha.2020.109959","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"2581_CR13","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.3892\/etm.2019.8037","volume":"18","author":"H Zhang","year":"2019","unstructured":"Zhang H (2019) Mechanism associated with aberrant LncRNA MEG3 expression in gestational diabetes mellitus. Exp Ther Med 18(5):3699\u20133706. https:\/\/doi.org\/10.3892\/etm.2019.8037","journal-title":"Exp Ther Med"},{"issue":"1\u20132","key":"2581_CR14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11010-020-03761-3","volume":"473","author":"WW Chang","year":"2020","unstructured":"Chang WW et al (2020) Upregulation of MEG3 in T2DM with vascular disease: A case-control study. Mol Cell Biochem 473(1\u20132):93\u201399. https:\/\/doi.org\/10.1007\/s11010-020-03761-3","journal-title":"Mol Cell Biochem"},{"issue":"8","key":"2581_CR15","doi-asserted-by":"publisher","first-page":"903","DOI":"10.17219\/acem\/121459","volume":"29","author":"Y Zhang","year":"2020","unstructured":"Zhang Y et al (2020) Expression and function of MALAT1 in gestational diabetes mellitus. Adv Clin Exp Med 29(8):903\u2013910. https:\/\/doi.org\/10.17219\/acem\/121459","journal-title":"Adv Clin Exp Med"},{"issue":"3","key":"2581_CR16","doi-asserted-by":"publisher","first-page":"716","DOI":"10.21037\/cdt-20-547","volume":"11","author":"Y Li","year":"2021","unstructured":"Li Y et al (2021) LncRNA XIST as a biomarker in GDM via miR-497-5p\/FOXO1 axis. Cardiovasc Diagn Ther 11(3):716\u2013725. https:\/\/doi.org\/10.21037\/cdt-20-547","journal-title":"Cardiovasc Diagn Ther"},{"key":"2581_CR17","doi-asserted-by":"publisher","first-page":"659093","DOI":"10.3389\/fendo.2021.659093","volume":"12","author":"C Yan","year":"2021","unstructured":"Yan C et al (2021) LncRNA MALAT1 promotes inflammation and insulin resistance by modulating NF-\u03baB signaling in T2D. Front Endocrinol (Lausanne) 12:659093. https:\/\/doi.org\/10.3389\/fendo.2021.659093","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2581_CR18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s10020-023-00727-1","volume":"29","author":"W Chen","year":"2023","unstructured":"Chen W et al (2023) MALAT1 promotes insulin resistance in T2D by targeting miR-382-3p\/resistin axis. Mol Med 29(1):52. https:\/\/doi.org\/10.1186\/s10020-023-00727-1","journal-title":"Mol Med"},{"issue":"4","key":"2581_CR19","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.bbrc.2019.12.114","volume":"523","author":"Y Zhang","year":"2020","unstructured":"Zhang Y et al (2020) Long noncoding RNA MALAT1 impairs \u03b2-cell function via PDX-1 suppression. Biochem Biophys Res Commun 523(4):1030\u20131036. https:\/\/doi.org\/10.1016\/j.bbrc.2019.12.114","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"2581_CR20","doi-asserted-by":"publisher","first-page":"e1506","DOI":"10.1038\/cddis.2014.466","volume":"5","author":"J Liu","year":"2014","unstructured":"Liu J et al (2014) MALAT1 induces endothelial dysfunction in diabetes via oxidative stress and VEGF. Cell Death Dis 5(10):e1506. https:\/\/doi.org\/10.1038\/cddis.2014.466","journal-title":"Cell Death Dis"},{"issue":"11","key":"2581_CR21","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1194\/jlr.M070094","volume":"57","author":"B Zhou","year":"2016","unstructured":"Zhou B et al (2016) LncRNA MALAT1 modulates hepatic lipid metabolism through SREBP-1c. J Lipid Res 57(11):2137\u20132149. https:\/\/doi.org\/10.1194\/jlr.M070094","journal-title":"J Lipid Res"},{"issue":"1","key":"2581_CR22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12967-023-04179-4","volume":"21","author":"Y Zhao","year":"2023","unstructured":"Zhao Y et al (2023) LncRNA MEG3 aggravates adipocyte inflammation and insulin resistance via IGF2BP2\/TLR4\/NF-\u03baB pathway. J Transl Med 21(1):289. https:\/\/doi.org\/10.1186\/s12967-023-04179-4","journal-title":"J Transl Med"},{"issue":"3","key":"2581_CR23","doi-asserted-by":"publisher","first-page":"R45","DOI":"10.1530\/JME-17-0221","volume":"60","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Zhang X, Klibanski A (2018) MEG3 noncoding RNA: A tumor suppressor. J Mol Endocrinol 60(3):R45\u2013R53. https:\/\/doi.org\/10.1530\/JME-17-0221","journal-title":"J Mol Endocrinol"},{"issue":"2","key":"2581_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1507\/endocrj.EJ21-0385","volume":"69","author":"X Sun","year":"2022","unstructured":"Sun X et al (2022) LncRNA MEG3 regulates autophagy and pyroptosis via FOXO1 in pancreatic \u03b2-cells. Endocr J 69(2):199\u2013210. https:\/\/doi.org\/10.1507\/endocrj.EJ21-0385","journal-title":"Endocr J"},{"issue":"10","key":"2581_CR25","doi-asserted-by":"publisher","first-page":"6020","DOI":"10.1111\/jcmm.14518","volume":"23","author":"L Yang","year":"2019","unstructured":"Yang L et al (2019) Long non-coding RNA MEG3 promotes fibrosis and inflammation in diabetic nephropathy via miR-181a\/Egr-1\/TLR4 axis. J Cell Mol Med 23(10):6020\u20136030. https:\/\/doi.org\/10.1111\/jcmm.14518","journal-title":"J Cell Mol Med"},{"issue":"1","key":"2581_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bbrc.2016.01.149","volume":"471","author":"T Zha","year":"2016","unstructured":"Zha T et al (2016) Long noncoding RNA MEG3 is involved in diabetes mellitus-related microvascular dysfunction. Biochem Biophys Res Commun 471(1):135\u2013141. https:\/\/doi.org\/10.1016\/j.bbrc.2016.01.149","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"2581_CR27","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.3390\/antiox13121503","volume":"13","author":"J Stevanovi\u0107","year":"2024","unstructured":"Stevanovi\u0107 J, Petrovi\u0107 U, Penezi\u0107 A, Radoji\u010di\u0107 O, Ardali\u0107 D, Mandi\u0107 M, Mandi\u0107-Markovi\u0107 V, Mikovi\u0107 \u017d, Brku\u0161anin M, Nedi\u0107 O et al (2024) LncRNAs involved in antioxidant response regulation as biomarkers of gestational diabetes: A study on H19, MALAT1 and MEG3. Antioxidants 13(12):1503. https:\/\/doi.org\/10.3390\/antiox13121503","journal-title":"Antioxidants"},{"key":"2581_CR28","doi-asserted-by":"publisher","unstructured":"Zhang X, Wang W, Zhu W, Dong J, Cheng Y, Yin Z, Shen F (2019) Mechanisms and Functions of Long Non-Coding RNAs at Multiple Regulatory Levels. Int J Mol Sci. ;20(22):5573. https:\/\/doi.org\/10.3390\/ijms20225573. PMID: 31717266","DOI":"10.3390\/ijms20225573"},{"issue":"11","key":"2581_CR29","doi-asserted-by":"publisher","first-page":"e969","DOI":"10.1002\/iid3.969","volume":"11","author":"G Zhong","year":"2023","unstructured":"Zhong G et al (2023) Long noncoding RNA XIST inhibits hepatic insulin resistance via miR-182-5p. Immun Inflamm Dis 11(11):e969. https:\/\/doi.org\/10.1002\/iid3.969","journal-title":"Immun Inflamm Dis"},{"issue":"Supplement1","key":"2581_CR30","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.2337\/dc20-S002","volume":"43","author":"AD Association","year":"2019","unstructured":"Association AD (2019) 2. Classification and diagnosis of diabetes: standards of medical care in Diabetes\u20142020. Diabetes Care 43(Supplement1):S14\u201331. https:\/\/doi.org\/10.2337\/dc20-S002","journal-title":"Diabetes Care"},{"issue":"11","key":"2581_CR31","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1111\/j.1651-2227.2010.01911.x","volume":"99","author":"SM R\u00f6ssner","year":"2010","unstructured":"R\u00f6ssner SM, Neovius M, Mattsson A, Marcus C, Norgren S (2010) HOMA-IR and QUICKI: decide on a general standard instead of comparisons. Acta Paediatr 99(11):1735\u20131740. https:\/\/doi.org\/10.1111\/j.1651-2227.2010.01911.x","journal-title":"Acta Paediatr"},{"issue":"Suppl 1","key":"2581_CR32","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1186\/s12864-015-2341-8","volume":"17","author":"G Terai","year":"2016","unstructured":"Terai G, Iwakiri J, Kameda T, Hamada M, Asai K (2016) Comprehensive prediction of lncRNA-RNA interactions in human transcriptome. BMC Genomics 17(Suppl 1):S8. https:\/\/doi.org\/10.1186\/s12864-015-2341-8","journal-title":"BMC Genomics"},{"issue":"3","key":"2581_CR33","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41591-019-0358-5","volume":"25","author":"OS Dallner","year":"2019","unstructured":"Dallner OS et al (2019) Dysregulation of LncRNA reduces leptin, leading to leptin-responsive obesity. Nat Med 25(3):507\u2013516. https:\/\/doi.org\/10.1038\/s41591-019-0358-5","journal-title":"Nat Med"},{"issue":"9","key":"2581_CR34","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s00424-020-02442-2","volume":"472","author":"A Chadt","year":"2020","unstructured":"Chadt A, Al-Hasani H (2020) Glucose transporters in metabolic health and disease. Pflugers Arch 472(9):1273\u20131298. https:\/\/doi.org\/10.1007\/s00424-020-02442-2","journal-title":"Pflugers Arch"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-025-02581-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-025-02581-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-025-02581-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T12:11:50Z","timestamp":1769515910000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00592-025-02581-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["2581"],"URL":"https:\/\/doi.org\/10.1007\/s00592-025-02581-5","relation":{},"ISSN":["1432-5233"],"issn-type":[{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,10]]},"assertion":[{"value":"7 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}